Microbiota and Cancer 4.0
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Oncology".
Deadline for manuscript submissions: 30 September 2024 | Viewed by 27
Special Issue Editors
Interests: human microbiome; gut microbiome; microbial ecology; host–microbiome interactions; probiotics; next-generation sequencing
Special Issues, Collections and Topics in MDPI journals
Interests: acute myeloid leukemia in children; pediatric myelodysplastic syndrome; hematopoietic stem cell transplantation in children; next-generation sequencing; characterization and modulation of gut microbiota during hematopoietic stem cell transplantation
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The human body is colonized by thousands of different microbial species that are essential to our survival. In the last 15 years, our knowledge of the human microbiome has increased exponentially. Thanks to next-generation DNA sequencing, metabolomics, and genobiotic models, we can dissect compositional and functional microbiome structures and elucidate the mechanisms underlying the role of the microbiome in human biology and pathology. Mounting evidence has suggested a critical role of the microbiome in host immune responses, specifically the host’s susceptibility to cancer and their response to cancer treatment. The impact of the gut microbiota on anticancer immune responses has represented an intriguing and evolving area of exploration in the recent literature. Novel metacommunity approaches have provided an integrative and extensive understanding of the tight link between the microbiome and cancer, and have offered new, exciting insights into possible therapeutic avenues.
This Special Issue titled “Microbiota and Cancer 4.0” will focus on the role of the human microbiome in the pathogenesis of cancer, in the host response to immunotherapy, in hematopoietic stem cell transplantation, and in possible microbiota-based therapeutic or pre-emptive strategies to manage treatment-related complications.
Authors are invited to submit original research articles and review papers which address the abovementioned topics in this Special Issue.
Dr. Silvia Turroni
Dr. Riccardo Masetti
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- gut microbiota
- cancer
- hematopoietic stem cell transplantation
- human microbiome
- immune system
- colon cancer
- carcinogenesis
- nutrition
- short-chain fatty acids
- metagenomic
- dysbiosis
